This research was completed To guage the prospective of the CPPs with tumor-targeting Attributes to deliver a cytotoxic payload to HCC cells. We explored utilizing a CXCR4-targeting peptide, T22, fused with cytotoxic peptide PE24, being a novel therapeutic system for CXCR4+ HCC cells. T22 was selected because the nanocarrier on https://aneurinl318ahm2.howeweb.com/profile